secwatch.observer — SEC 8-K summary
======================================

Issuer:     TherapeuticsMD, Inc. (TXMD)
CIK:        0000025743
Form:       8-K
Filed at:   2024-09-20T23:59:59+00:00
Accession:  0001213900-24-080719
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.08
LLM model:  deepseek-v4-flash:cloud@v2

TherapeuticsMD sets 2024 annual meeting for Dec 5; proxy deadlines Sep 30
-------------------------------------------------------------------------

- 2024 Annual Meeting scheduled for December 5, 2024; record date October 17, 2024.
- Stockholder proposals for inclusion in proxy materials (Rule 14a-8) must be received by September 30, 2024.
- Director nominations and other proposals must also be submitted by close of business September 30, 2024.
- Meeting is more than 30 days after anniversary of 2023 meeting, triggering revised deadlines.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/25743/000121390024080719/0001213900-24-080719-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/25743/000121390024080719/ea0215273-8k_therap.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-080719

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer